Cleared Traditional

K023627 - ESSEX ENDOSCOPE, MODEL SXD-1000

K023627 is an FDA 510(k) clearance for ESSEX ENDOSCOPE, manufactured by Guidant Corp.. The device is a Class 2 General & Plastic Surgery device with product code GCJ cleared through the Traditional 510(k) pathway after a 15-day FDA review.

K023627 · Guidant Corp. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2002
Decision
15d
Days
Class 2
Risk

K023627 is an FDA 510(k) clearance for the ESSEX ENDOSCOPE, MODEL SXD-1000. Classified as Laparoscope, General & Plastic Surgery (product code GCJ), Class II - Special Controls.

Submitted by Guidant Corp. (Santa Clara, US). The FDA issued a Cleared decision on November 12, 2002 after a review of 15 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 876.1500 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Guidant Corp. devices

FDA 510(k) Submission Details - K023627

510(k) Number K023627 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 28, 2002
Decision Date November 12, 2002
Days to Decision 15 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
100d faster than avg
Panel avg: 115d · This submission: 15d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

GCJ Device Classification - Class 2, Special Controls

Product Code GCJ Laparoscope, General & Plastic Surgery
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1500
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

N.V. Kema
MICHELLE WEIDMAN

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GCJ Laparoscope, General & Plastic Surgery

All 1075
Devices cleared under the same product code (GCJ) and FDA review panel - the closest regulatory comparables to K023627.
MODIFICATION TO HERMES OPERATING ROOM CONTROL CENTER
K024294 · Computer Motion, Inc. · Jan 2003
ADAPT BALLOON OPEN ACCESS PORT, MODEL 41244
K023261 · Taut, Inc. · Dec 2002
HERMES OPERATING ROOM CONTROL CENTER
K023095 · Computer Motion, Inc. · Nov 2002
MODIFICATION TO HERMES OPERATING ROOM CONTROL CENTER
K022897 · Computer Motion, Inc. · Oct 2002
DYONICS VISION 635 IMAGE MANAGEMENT SYSTEM
K023053 · Smith & Nephew, Inc. · Oct 2002
ADAPT OPEN ACCESS PORT, MODEL 41233
K021731 · Taut, Inc. · Aug 2002

FDA 510(k) Resources - General & Plastic Surgery

Additional regulatory intelligence related to this FDA 510(k) submission, including predicate strategy, review pathways and device classification guidance.